Literature DB >> 16378160

Long-term outcomes in patients with calciphylaxis from hyperparathyroidism.

Allison Duffy1, Michael Schurr, Thomas Warner, Herbert Chen.   

Abstract

BACKGROUND: Calciphylaxis is a rare condition associated with chronic renal failure and entails a very poor prognosis. Pathogenesis is poorly understood but involves abnormalities in calcium and phosphorus metabolism that lead to vascular and extravascular calcification. Patients present with painful ulcerating plaques that progress to gangrenous wounds. Parathyroidectomy has been advanced as a life-saving intervention in these patients, but long-term results with wound healing and survival after parathyroidectomy are not well described.
METHODS: Between January 1987 and October 2003, 15 patients with biopsy-confirmed calciphylaxis were treated at the University of Wisconsin. Of these 15 patients, 9 were treated with medical therapy (bisphosphonates and phosphate binders), whereas 6 underwent parathyroidectomy. The medical records were reviewed, and patients or relatives were interviewed. Survival was determined by Kaplan-Meier analysis.
RESULTS: Four patients underwent subtotal parathyroidectomy, and two patients underwent total parathyroidectomy. All had reductions in the intact parathyroid hormone level (mean +/- SD, 25.2 +/- 4.5 pg/mL). Whereas all six patients treated with parathyroidectomy had partial/complete wound healing, only two of nine in the medical group had any improvements in the skin lesions (P = .006). With up to 80 months of follow-up, patients who underwent parathyroidectomy had a longer median survival compared with those who did not have surgery (39 vs. 3 months; P = .017).
CONCLUSIONS: On the basis of our long-term follow-up of this patient population, subtotal or total parathyroidectomy was associated with long-term survival and was more likely to promote healing if performed earlier in the course of disease. Therefore, patients with calciphylaxis from secondary hyperparathyroidism should be referred promptly for potential parathyroidectomy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16378160     DOI: 10.1245/ASO.2006.03.042

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  10 in total

Review 1.  [Indications for parathyroidectomy in renal hyperparathyroidism: comments on the significance of new therapeutics].

Authors:  C Dotzenrath
Journal:  Chirurg       Date:  2010-10       Impact factor: 0.955

2.  Secondary hyperparathyroidism: Uncommon cause of a leg ulcer.

Authors:  L B van Rijssen; E E A Brenninkmeijer; E J M Nieveen van Dijkum
Journal:  Int J Surg Case Rep       Date:  2011-10-28

3.  Painful skin ulcers in a hemodialysis patient.

Authors:  Stuart M Sprague
Journal:  Clin J Am Soc Nephrol       Date:  2013-11-07       Impact factor: 8.237

4.  Calciphylaxis associated with widespread pulmonary calcification.

Authors:  Tarvinder Singh Dhanjal; Suresh B Babu; Gareth Beevers; Robin E Ferner
Journal:  BMJ Case Rep       Date:  2009-03-20

5.  Removing the problem: parathyroidectomy for calciphylaxis.

Authors:  Mohamed Hassanein; Heather Laird-Fick; Richa Tikaria; Saleh Aldasouqi
Journal:  BMJ Case Rep       Date:  2018-12-22

Review 6.  The surgical management of renal hyperparathyroidism.

Authors:  Catherine Madorin; Randall P Owen; William D Fraser; Phillip K Pellitteri; Brian Radbill; Alessandra Rinaldo; Raja R Seethala; Ashok R Shaha; Carl E Silver; Matthew Y Suh; Barrie Weinstein; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-11-20       Impact factor: 2.503

7.  Calcific uremic arteriolopathy: an underrecognized entity.

Authors:  Victoria Ann Kumar
Journal:  Perm J       Date:  2011

Review 8.  Surgical and medical treatment of secondary hyperparathyroidism in patients on continuous dialysis.

Authors:  Yoshihiro Tominaga; Susumu Matsuoka; Nobuaki Uno
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

Review 9.  Cutaneous manifestations of ESRD.

Authors:  Timur A Galperin; Antonia J Cronin; Kieron S Leslie
Journal:  Clin J Am Soc Nephrol       Date:  2013-10-10       Impact factor: 8.237

10.  Calcific uremic arteriolopathy in peritoneal dialysis populations.

Authors:  Nicholas New; Janaki Mohandas; George T John; Sharad Ratanjee; Helen Healy; Leo Francis; Dwarakanathan Ranganathan
Journal:  Int J Nephrol       Date:  2011-06-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.